OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders
Esi Domi, Estelle Barbier, Eric Augier, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 9, pp. 1805-1812
Open Access | Times Cited: 66

Dynorphin and its role in alcohol use disorder
Anushree N. Karkhanis, Ream Al‐Hasani
Brain Research (2020) Vol. 1735, pp. 146742-146742
Open Access | Times Cited: 40

Pharmacological Treatments for Alcohol Use Disorder: Considering the Role of Sex and Gender
Dylan Kirsch, Malia A. Belnap, Elizabeth M. Burnette, et al.
Current Addiction Reports (2024) Vol. 11, Iss. 1, pp. 81-93
Closed Access | Times Cited: 5

The Role of Endogenous Beta-Endorphin and Enkephalins in the Crosstalk Between Ethanol and Morphine
Andy Tseng, Syed Muzzammil Ahmad, Abdul Hamid, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 107-107
Open Access

Combination of Clinically Utilized Kappa‐Opioid Receptor Agonist Nalfurafine With Low‐Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice
Yan Zhou, Mary Jeanne Kreek
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 6, pp. 1077-1090
Open Access | Times Cited: 21

Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist
Yan Zhou, Kevin B. Freeman, Vincent Setola, et al.
Handbook of experimental pharmacology (2021), pp. 137-162
Open Access | Times Cited: 16

Efficacy of N‐acetylcysteine in the prevention of alcohol relapse‐like drinking: Study in long‐term ethanol‐experienced male rats
M. J. Cano‐Cebrián, Sandra Fernández‐Rodríguez, Lucía Hipólito, et al.
Journal of Neuroscience Research (2020) Vol. 99, Iss. 2, pp. 638-648
Open Access | Times Cited: 11

Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor
Na Qu, Ruizhe Wang, Yiming Meng, et al.
International Immunopharmacology (2022) Vol. 110, pp. 108933-108933
Closed Access | Times Cited: 6

Exploring the Putative Mechanism of Allosteric Modulations By Mixed-Action Kappa/Mu Opioid Receptor Bitopic Modulators
Huiqun Wang, Danni Cao, James C. Gillespie, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 6, pp. 551-573
Open Access | Times Cited: 6

Antagonists of the stress and opioid systems restore the functional connectivity of the prefrontal cortex during alcohol withdrawal through divergent mechanisms
Lieselot L. G. Carrette, Aline Valéria Sousa Santos, Molly Brennan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

Emerging GPCR targets for AUD: Insights from preclinical studies
Roberta G. Anversa, Maiya L. Barron, Leigh C. Walker, et al.
Current Opinion in Neurobiology (2024) Vol. 87, pp. 102896-102896
Open Access

Role of Metabolism on Alcohol Preference, Addiction, and Treatment
Marı́a Elena Quintanilla, Yedy Israel
Current topics in behavioral neurosciences (2023)
Closed Access

Page 1

Scroll to top